LivaNova PLC (LIVN)
LivaNova PLC (LIVN)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 539,706 | 635,552 | 646,079 | 593,638 |
| Restricted cash | NaN | 0 | 0 | 0 |
| Accounts receivable, net of allowance of 10,309 as of march31, 2026 and 12,527 as of december31, 2025 | 229,273 | 215,985 | 211,579 | 220,195 |
| Inventories | 165,504 | 164,701 | 167,538 | 165,350 |
| Prepaid and refundable taxes | 41,272 | 48,606 | 27,531 | 32,785 |
| Prepaid expenses and other current assets | 38,482 | 36,769 | 44,422 | 54,174 |
| Total current assets | 1,014,237 | 1,101,613 | 1,097,149 | 1,066,142 |
| Property, plant, and equipment, net | 255,483 | 242,603 | 218,510 | 195,418 |
| Investments | NaN | NaN | 15,049 | 16,163 |
| Goodwill | 785,590 | 792,840 | 791,034 | 793,365 |
| Intangible assets, net | 224,556 | 229,964 | 234,530 | 239,143 |
| Operating lease assets | 54,532 | 55,519 | 51,197 | 50,677 |
| Investments | 18,492 | 20,291 | NaN | NaN |
| Deferred tax assets | 109,816 | 110,983 | 107,305 | 109,810 |
| Long-term derivative assets | 38,277 | 36,551 | 28,011 | 21,658 |
| Other assets | 15,368 | 15,689 | 14,798 | 14,326 |
| Total assets | 2,516,351 | 2,606,053 | 2,557,583 | 2,506,702 |
| Current debt obligations | 2,628 | 31,472 | 85,440 | 82,133 |
| Accounts payable | 99,148 | 97,157 | 88,156 | 86,934 |
| Legal and professional costs | NaN | NaN | 18,481 | NaN |
| Italian medtech payback measure | NaN | NaN | 12,255 | NaN |
| Contract liabilities | NaN | NaN | 11,084 | NaN |
| Operating lease liabilities | NaN | NaN | 9,001 | NaN |
| Provisions for agents, returns, and other | NaN | NaN | 4,948 | NaN |
| Royalty accrual | NaN | NaN | 4,660 | NaN |
| Interest payable | NaN | NaN | 3,235 | NaN |
| Current derivative liabilities | NaN | NaN | 1,888 | NaN |
| Research and development costs | NaN | NaN | 1,353 | NaN |
| Restructuring liabilities | NaN | NaN | 0 | NaN |
| Other accrued expenses | NaN | NaN | 25,324 | NaN |
| Accrued liabilities and other | 102,649 | 94,573 | 92,229 | 103,240 |
| Snia environmental liability | 389,485 | 396,242 | 394,587 | 392,268 |
| Current contingent consideration | 59,589 | 50,030 | 49,041 | 48,265 |
| Current litigation provision liability | 9,643 | 12,552 | 16,499 | 12,171 |
| Taxes payable | 41,704 | 33,133 | 21,373 | 34,495 |
| Accrued employee compensation and related benefits | 57,632 | 92,913 | 80,263 | 67,594 |
| Total current liabilities | 762,478 | 808,072 | 827,588 | 827,100 |
| Long-term debt obligations | 285,160 | 345,185 | 349,031 | 348,489 |
| Long-term contingent consideration | 43,141 | 42,045 | 40,641 | 39,662 |
| Deferred tax liabilities | 6,812 | 9,590 | 10,096 | 11,392 |
| Long-term operating lease liabilities | 46,696 | 48,327 | 43,075 | 42,777 |
| Long-term employee compensation and related benefits | 13,105 | 13,574 | 13,543 | 13,651 |
| Long-term derivative liabilities | 93,254 | 83,904 | 64,515 | 48,093 |
| Other long-term liabilities | 54,379 | 55,369 | 51,864 | 52,699 |
| Total liabilities | 1,305,025 | 1,406,066 | 1,400,353 | 1,383,863 |
| Ordinary shares, 1.00 par value unlimited shares authorized 55,537,746 shares issued and 54,901,316 shares outstanding as of march31, 2026 55,535,181 shares issued and 54,649,085 shares outstanding as of december31, 2025 | 84,564 | 84,564 | 84,520 | 84,521 |
| Additional paid-in capital | 2,254,756 | 2,254,980 | 2,245,024 | 2,234,777 |
| Accumulated other comprehensive (loss) income | -3,401 | 7,330 | 5,508 | 8,113 |
| Accumulated deficit | -1,123,427 | -1,145,721 | -1,176,627 | -1,203,411 |
| Treasury shares at cost, 636,430 ordinary shares as of march31, 2026 886,096 ordinary shares as of december31, 2025 | 1,166 | 1,166 | 1,195 | 1,161 |
| Total shareholders equity | 1,211,326 | 1,199,987 | 1,157,230 | 1,122,839 |
| Total liabilities and shareholders equity | 2,516,351 | 2,606,053 | 2,557,583 | 2,506,702 |